Predictive Values of NLR, PLR and MPV for Pre-Eclampsia in Pregnancy: A Retrospective Cross-Sectional Study in a Teaching Hospital, Ghana
International Journal of Research and Reports in Hematology,
Aim: To assess the predictive values of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and mean platelet volume (MPV) for pre-eclampsia in pregnancy.
Study Design: Retrospective cross-sectional study.
Place and Duration of Study: Obstetrics and Gynecology unit of Tamale Teaching Hospital, Tamale, Ghana from 1st January, 2021 to 31st December, 2021.
Methodology: The study recruited 161 pregnant women (79 pre-eclamptic pregnant women and 82 apparently healthy pregnant women as controls). Full blood count parameters were assessed using fully automated haematology analyzer. Neutrophil/lymphocyte ratio, and platelet/lymphocyte ratio were calculated. Data analysis was done with SPSS version 22.0 and P<0.05 was considered statistically significant.
Results: Pregnant women with PE had lower parity (P< .001) and gestational ages (P< .001) than their counterparts without PE. Haemoglobin (P= .007), red blood cells (P= .003), haematocrit (P= .01), absolute monocyte (P= .001) and MPV (P= .02) were significantly higher in the PE group compared to the controls. Also, pregnant women with PE had relatively higher MPV compared with the apparently healthy pregnant women without pre-eclampsia (P= .02), but NLR and PLR were not different between the two groups. Again, MPV significantly predicted PE (AUC: 0.609, P< .02) in pregnancy than NLR and PLR.
Conclusion: Lower parity and gestational ages are significantly associated with pre-eclampsia. Hb, RBC, HCT, absolute monocyte count and MPV were higher in pre-eclamptic pregnant women. MPV is a better marker for predicting asymptomatic PE in pregnancy. NLR and PLR did not significantly predict PE in pregnancy.
- Haematological profile
How to Cite
Witlin A, Sibai B. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet. Gynecol. 1998;92:883–889.
Vata PK, Chauhan NM, Nallathambi A, et al. Assessment of prevalence of preeclampsia from Dilla region of Ethiopia. BMC Res. Notes. 2015;8:1–6.
Nakimuli A, Chazara O, Byamugisha J, et al. Pregnancy, parturition and preeclampsia in women of African ancestry. Am. J. Obstet. Gynecol. 2014; 210:510–520.
WHO. The World health report: 2005: Make every mother and child count. (World Health Organization); 2005.
Owiredu W, Ahenkorah L, Turpin CA, et al. Putative risk factors of pregnancy-induced hypertension among Ghanaian pregnant women. J. Med. Biomed. Sci. 2012;1:62–76.
Obed SA, Patience A. Birth weight and ponderal index in pre-eclampsia: A comparative study. Ghana Med. J. 2006;40:8.
Hung TH, Skepper JN, Charnock-Jones DS, et al. Hypoxia-reoxygenation: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ. Res. 2002;90:1274–1281.
McKeeman GC, Ardill JES, Caldwell CM, et al. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am. J. Obstet. Gynecol. 2004;191:1240–1246.
Widmer M, Villar J, Benigni A, et al. Mapping the theories of preeclampsia and the role of angiogenic factors: A systematic review. Obstet. Gynecol. 2007;109:168–180.
Yücel B, Ustun B. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia. Pregnancy Hypertens. An Int. J. Women’s Cardiovasc. Heal. 2017;7:29–32.
Vilchez G, Lagos M, Kumar K, et al. Is mean platelet volume a better biomarker in pre‐eclampsia? J. Obstet. Gynaecol. Res. 2017;43:982–990.
Abor PA. Managing healthcare waste in Ghana: A comparative study of public and private hospitals. Int. J. Health Care Qual. Assur; 2013.
Han L, Liu X, Li H. Blood coagulation parameters and platelet indices: Changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS One. 2014;9:e114488.
Kashanian M, Hajjaran M, Khatami E, et al. Evaluation of the value of the first and third trimester maternal mean platelet volume (MPV) for prediction of pre-eclampsia. Pregnancy Hypertens. An Int. J. Women’s Cardiovasc. Heal. 2013;3:222–226.
Kurt RK, Aras Z, Silfeler D, et al. Relationship of red cell distribution width with the presence and severity of preeclampsia. Clin. Appl. Thromb. 2015;21:128–131.
Ghana Statistical Service. Tamale metropolis. District Analytical Report: Tamale Metropolis, Ghana; 2014.
American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet. Gynecol. 2013;122:1122–1131.
Nkansah C, Addai-Mensah O, Mensah K, et al. Plasminogen activator inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana. PLoS ONE. 2021;16:e0250090.
Snydal S. Major changes in diagnosis and management of preeclampsia. J. Midwifery Womens. Health. 2014;59:596–605.
Çintesun E, Çintesun FNI, Ezveci H, et al. Systemic inflammatory response markers in preeclampsia. J. Lab. Physicians. 2018;10:316–319.
Serhal P, Craft I. Immune basis for pre-eclampsia evidence from oocyte recipients. Lancet (London, England). 1987;2:744.
Duley L. The global impact of pre-eclampsia and eclampsia. Seminars in perinatology. Elsevier. 2009;33:130–137.
Mannaerts D, Heyvaert S, De Cordt C, et al. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J. Matern. Neonatal Med. 2019;32:1412–1419.
Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am. J. Obstet. Gynecol. 1984;148:951–963.
Chappell L, Bewley S. Pre‐eclamptic toxaemia: The role of uterine artery Doppler. BJOG An Int. J. Obstet. Gynaecol. 1998;105:379–382.
Walker JJ. Pre-eclampsia. Lancet. 2000; 356:1260–1265.
Gezer C, Ekin A, Ertas IE, et al. High first-trimester neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia. Ginekol. Pol. 2016;87:431–435.
Järemo P, Lindahl T, Lennmarken C, et al. The use of platelet density and volume measurements to estimate the severity of pre‐eclampsia. Eur. J. Clin. Invest. 2000;30:1113–1118.
Freitas LG, Alpoim PN, Komatsuzaki F, et al. Preeclampsia: Are platelet count and indices useful for its prognostic? Hematology 2013;18:360–364.
Dundar O, Yoruk P, Tutuncu L, et al. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre‐eclampsia. Prenat. Diagnosis Publ. Affil. With Int. Soc. Prenat. Diagnosis 2008;28:1052–1056.
Piazze J, Gioia S, Maranghi L, et al. Mean platelet and red blood cell volume measurements to estimate the severity of hypertension in pregnancy. J. Perinat. Med. 2006;34:246–247.
Stubbs TM, Lazarchick J, Van Dorsten JP, et al. Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am. J. Obstet. Gynecol. 1986;155:263–265.
Gladwin AM, Martin JF. The control of megakaryocyte ploidy and platelet production: Biology and pathology. Int. J. Cell Cloning. 1990;8:291–298.
Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 1988;72:1-8.
Serin S, Avcı F, Ercan O, et al. Is neutrophil/lymphocyte ratio a useful marker to predict the severity of pre-eclampsia? Pregnancy Hypertens. An Int. J. Women’s Cardiovasc. Heal. 2016;6:22–25.
Yavuzcan A, Caglar M, Ustun Y, et al. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekol. Pol. 2014;85(3). DOI: 10.17772/gp/1713
Kirbas A, Ersoy AO, Daglar K, et al. Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters. J. Clin. diagnostic Res. 2015;9:QC20.
Abstract View: 403 times
PDF Download: 24 times